Filing Details
- Accession Number:
- 0001127602-11-013449
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-21 13:00:00
- Reporting Period:
- 2011-04-20
- Filing Date:
- 2011-04-21
- Accepted Time:
- 2011-04-21 16:41:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236534 | Lynn Schenk | Biogen Idec Inc. 133 Boston Post Road Weston MA 02493 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-04-20 | 10,000 | $68.15 | 17,980 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-04-20 | 10,000 | $85.81 | 7,980 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-04-20 | 12,500 | $66.29 | 20,480 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-04-20 | 3,125 | $46.99 | 23,605 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-04-20 | 5,950 | $52.22 | 29,555 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-04-20 | 5,700 | $59.17 | 35,255 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-04-20 | 27,275 | $85.00 | 7,980 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-04-20 | 10,000 | $0.00 | 10,000 | $68.15 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-04-20 | 12,500 | $0.00 | 12,500 | $66.29 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2011-04-20 | 3,125 | $0.00 | 3,125 | $46.99 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-04-20 | 5,950 | $0.00 | 5,950 | $52.22 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-04-20 | 5,700 | $0.00 | 5,700 | $59.17 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2003-01-02 | 2012-01-01 | No | 4 | M | Direct |
| 0 | 2015-01-03 | No | 4 | M | Direct | |
| 0 | 2016-05-24 | No | 4 | M | Direct | |
| 0 | 2017-05-30 | No | 4 | M | Direct | |
| 0 | 2009-06-19 | 2018-06-18 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 7,600 | Indirect | By Trust |
Footnotes
- Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- This represents the weighted average price for shares sold at a range between $85.78 (low) and $85.86 (high).
- Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).
- Immediately exercisable for all the option shares on grant date of 01/03/2005 subject to Issuer's repurchase rights which lapse on 01/03/2006.
- Options will vest in their entirety on 05/25/2007 provided that the Reporting Owner is then a member of the Issuer's Board of Directors.
- Options will become 100% exercisable upon completion of one year of service with Biogen Idec Inc.
Billionaire Hedge Funds
